Pharmacokinetics and pharmacodynamics of ticagrelor in patients with stable coronary artery disease: results from the onset-offset and respond studies
Clinical Pharmacokinetics,  Clinical Article

Husted SE et al. – Ticagrelor pharmacokinetics in stable coronary artery disease (CAD) patients were comparable to previous findings in stable atherosclerotic and acute coronary syndromes (ACS) patients, and were not affected by prior clopidogrel exposure or clopidogrel responsiveness. Ticagrelor effectively inhibited platelet aggregation, and trough plasma concentrations of ticagrelor and AR–C124910XX were sufficient to result in high IPA in stable CAD patients.

Methods
  • Patients were treated with ticagrelor (180mg loading dose, 90mg twice daily maintenance dose) or clopidogrel (600mg loading dose, 75mg once daily maintenance dose) in addition to aspirin (acetylsalicylic acid) [75–100mg once daily].
  • Ticagrelor administration was for 6 weeks in ONSET–OFFSET.
  • In RESPOND, ticagrelor was given for 14 days before or after 2 weeks of clopidogrel in patients classified as clopidogrel responders or non–responders.
  • Pharmacokinetics and IPA were evaluated following the loading and last maintenance doses.
  • Exposure–IPA relationships were evaluated using a sigmoid maximum effect (Emax) model.
  • The outcome measures were ticagrelor and AR–C124910XX (active metabolite) pharmacokinetics and exposure–IPA relationships in both trials, including the effect of prior clopidogrel exposure, and effects in clopidogrel responders and non–responders in RESPOND.

Results
  • In ONSET–OFFSET, maximum (peak) plasma concentration (Cmax), time to Cmax (tmax) and area under the plasma concentration–time curve from time 0 to 8 hours (AUC8) for ticagrelor were 733ng/mL, 2.0 hours and 4130ng•h/mL, respectively; and for AR–C124910XX were 210ng/mL, 2.1 hours and 1325ng•h/mL, respectively.
  • Emax estimates were IPA >97%.
  • Trough plasma ticagrelor (305ng/mL) and AR–C124910XX (121ng/mL) concentrations were 5.2 and 7.7 times higher than respective concentration producing 50% of maximum effect (EC50) estimates.
  • In RESPOND, ticagrelor mean Cmax and AUC8 following 2–week dosing were comparable between clopidogrel responders (724ng/mL and 3983ng•h/mL, respectively) and non–responders (764ng/mL and 3986ng•h/mL, respectively).
  • Pharmacokinetics of ticagrelor were unaffected by prior clopidogrel dosing.
  • Emax estimates were IPA >96% for both responders and non–responders.
  • Trough plasma concentrations were sufficient to achieve high IPA.

Please login or register to follow this author.
Are you sure you want to Unfollow this Author?
► Click here to access PubMed, Publisher and related articles...
<< Previous Article | Next Article >>

Your Unread Messages in Nursing

See All >> Messages include industry-sponsored communications and special communications from MDLinx

Most Popular Nursing Articles

1 Older brains slow due to greater experience, rather than cognitive decline Full Text EurekAlert!, January 22, 2014    Free full text

2 Yogurt and weight management American Journal of Clinical Nutrition, April 3, 2014    Review Article

3 Tea consumption and leukemia risk: A meta-analysis Tumor Biology, February 12, 2014    Evidence Based Medicine    Clinical Article

4 The effect of chromium supplementation on polycystic ovary syndrome in adolescents Journal of Pediatric and Adolescent Gynecology , May 30, 2014    Clinical Article

5 Effect of a low-flatulogenic diet in patients with flatulence and functional digestive symptoms Neurogastroenterology & Motility, February 25, 2014    Clinical Article
Exclusive Author Commentary

6 Do patients in a vegetative state recognize loved ones? Full Text EurekAlert!, December 18, 2013    Free full text

7 Long-term coffee consumption and risk of cardiovascular disease Circulation, February 11, 2014    Evidence Based Medicine    Review Article    Clinical Article

8 Egg consumption and insulin metabolism in the Insulin Resistance Atherosclerosis Study (IRAS) Public Health Nutrition, June 24, 2014    Clinical Article

9 Consumption of nuts and legumes and risk of incident ischemic heart disease, stroke, and diabetes: a systematic review and meta-analysis American Journal of Clinical Nutrition, June 19, 2014    Evidence Based Medicine    Review Article

10 Yogurt consumption, weight change and risk of overweight/obesity: The SUN cohort study Nutrition, Metabolism & Cardiovascular Diseases, July 15, 2014    Clinical Article

11 Ticks may cause double trouble, Stanford scientists find Full Text EurekAlert!, February 21, 2014    Free full text

12 Chikungunya poised to invade the Americas Full Text EurekAlert!, April 9, 2014    Free full text

13 Long-term associations of nut consumption with body weight and obesity American Journal of Clinical Nutrition, June 23, 2014    Clinical Article

14 Vitamin D status associated with multiple sclerosis activity, progression Full Text EurekAlert!, January 21, 2014    Free full text

15 Grape consumption may offer benefits for symptomatic knee osteoarthritis Full Text EurekAlert!, May 13, 2014    Free full text

16 The Mediterranean-style diet pattern and mortality among men and women with cardiovascular disease American Journal of Clinical Nutrition, November 1, 2013    Clinical Article

17 Chocolate intake and diabetes risk Clinical Nutrition, July 21, 2014    Clinical Article

18 Nut consumption for vascular health and cognitive function Nutrition Research Reviews, July 14, 2014    Review Article

19 Low-dose rapamycin (sirolimus) effects in autosomal dominant polycystic kidney disease: An open-label randomized controlled pilot study Clinical Journal of the American Society of Nephrology, May 23, 2014    Clinical Article

20 Yogurt consumption, weight change and risk of overweight/obesity: The SUN cohort study Nutrition, Metabolism & Cardiovascular Diseases, July 28, 2014    Clinical Article

Indexed Journals in Nursing: Journal of Advanced Nursing, Journal of Clinical Nursing, Nurse Education In Practicemore

Register now to view all the MDLinx contents (FREE)!

  • Stay current on the latest literature, research and clinical news
  • Get special communications and offers from MDLinx and our sponsors
  • Receive invitations to paid market research
View Samples and Register

Connect with us, stay current.

Receive the latest mecial news
updates for free via email

Sign up!

Subscribe to our free RSS feeds:

Get the latest news in your specialty automatically added to your newsreader or your personal My Yahoo!, Google, My MSN or My AOL page. Learn More

Close